Design of an in vitro biocatalytic cascade for the manufacture of islatravir
Merck & Co., Inc., Rahway, NJ, USA (United States) · Codexis (United States)
Abstract
Enzyme-catalyzed reactions have begun to transform pharmaceutical manufacturing, offering levels of selectivity and tunability that can dramatically improve chemical synthesis. Combining enzymatic reactions into multistep biocatalytic cascades brings additional benefits. Cascades avoid the waste generated by purification of intermediates. They also allow reactions to be linked together to overcome an unfavorable equilibrium or avoid the accumulation of unstable or inhibitory intermediates. We report an in vitro biocatalytic cascade synthesis of the investigational HIV treatment islatravir. Five enzymes were engineered through directed evolution to act on non-natural substrates. These were combined with four…
Citation impact
- FWCI
- 26.40
- Percentile
- 100%
- References
- 46
Authors
35- MAMark A. HuffmanCorresponding
Merck & Co., Inc., Rahway, NJ, USA (United States)
- AFAnna FryszkowskaCorresponding
Merck & Co., Inc., Rahway, NJ, USA (United States)
- OAOscar Alvizo
Codexis (United States)
- MBMargie Borra‐Garske
Codexis (United States)
- KRKevin R. Campos
Merck & Co., Inc., Rahway, NJ, USA (United States)
Topics & keywords
- Cascade
- In vitro
- Biochemical engineering
- Chemistry
- Engineering
- Biochemistry
- Chromatography
- Good health and well-being